MC, Á., S, O., G, C., M, C., J, O., P, S., . . . E, M. (2021). Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice. Dove Medical Press.
Chicago Style (17th ed.) CitationMC, Álamo, et al. Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice. Dove Medical Press, 2021.
MLA (8th ed.) CitationMC, Álamo, et al. Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice. Dove Medical Press, 2021.
Warning: These citations may not always be 100% accurate.